Catechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responses.

Catechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responses.

A large number of unwanted adverse events and symptoms reported by patients in clinical trials are not caused by the drug provided, since most of adverse events also occur in corresponding placebo groups. These nocebo effects also play a major role in drug discontinuation in clinical practice, negat...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Laura Wendt, Antje Albring, Sven Benson, Harald Engler, Andrea Engler, Anke Hinney, Winfried Rief, Oliver Witzke, Manfred Schedlowski
פורמט: Article
שפה:English
יצא לאור: Public Library of Science (PLoS) 2014-01-01
סדרה:PLoS ONE
גישה מקוונת:http://europepmc.org/articles/PMC4164653?pdf=render

פריטים דומים

פריטים דומים